Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217 (Q58007481)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217	article

Statements

scholarly article

0 references

academic journal article

0 references

Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217 (English)

0 references

coronary artery disease

0 references

Familial hypercholesterolaemia

0 references

arteriosclerotic heart disease

0 references

low-density lipoprotein

0 references

hypercholesterolemia

0 references

object named as

Marianne Benn

1

0 references

Anne Tybjærg-Hansen

3

object named as

Anne Tybjærg-Hansen

0 references

Børge G. Nordestgaard

4

object named as

Børge G. Nordestgaard

0 references

2

object named as

Gerald F. Watts

0 references

language of work or name

0 references

publication date

22 February 2016

0 references

European Heart Journal

0 references

37

0 references

17

0 references

1384-1394

0 references

Familial hypercholesterolemia and coronary heart disease: a HuGE association review

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHW028

21 January 2018

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHW028

21 January 2018

Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHW028

21 January 2018

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHW028

21 January 2018

Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHW028

21 January 2018

Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHW028

21 January 2018

Improving identification of familial hypercholesterolaemia in primary care: derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHW028

21 January 2018

Prevalence and treatment of familial hypercholesterolaemia in Australian communities

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHW028

21 January 2018

Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHW028

21 January 2018

Genetically elevated C-reactive protein and ischemic vascular disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHW028

21 January 2018

2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHW028

21 January 2018

Familial hypercholesterolaemia: a model of care for Australasia.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHW028

21 January 2018

Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHW028

21 January 2018

Spectrum of LDL receptor gene mutations in Denmark: implications for molecular diagnostic strategy in heterozygous familial hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHW028

21 January 2018

The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish population.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHW028

21 January 2018

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHW028

21 January 2018

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHW028

21 January 2018

Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHW028

21 January 2018

Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHW028

21 January 2018

Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHW028

21 January 2018

Discriminative ability of LDL-cholesterol to identify patients with familial hypercholesterolemia: a cross-sectional study in 26,406 individuals tested for genetic FH.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHW028

21 January 2018

Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHW028

21 January 2018

Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHW028

21 January 2018

The risk of tendon xanthomas in familial hypercholesterolaemia is influenced by variation in genes of the reverse cholesterol transport pathway and the low-density lipoprotein oxidation pathway

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHW028

21 January 2018

Canadian Cardiovascular Society position statement on familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHW028

21 January 2018

Family history and cardiovascular risk in familial hypercholesterolemia: data in more than 1000 children

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHW028

21 January 2018

Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHW028

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHW028

0 references

Google Scholar paper ID

4615747617498082427

0 references

PubMed publication ID

0 references

2-s2.0-84966551189

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58007481&oldid=2167597071"